Aster DM Quality Care (ASTERDM)₹733.50−2.12%Hospital
In the Jun 2026 quarter (consolidated), Aster DM Quality Care reported sales of ₹1,312 Cr, up 21.6% from Jun 2025, and net profit of ₹28.94 Cr, down 69.2% year on year. For the year to Mar 2026, sales were ₹4,649 Cr and net profit ₹426 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 929 | 956 | 974 | 1,002 | 1,087 | 1,051 | 1,001 | 1,078 | 1,198 | 1,188 | 1,184 | 1,312 |
| Expenses | 784 | 803 | 814 | 838 | 867 | 862 | 815 | 874 | 959 | 980 | 955 | 1,051 |
| Operating Profit | 142 | 149 | 156 | 161 | 218 | 186 | 182 | 203 | 236 | 203 | 225 | 257 |
| OPM % | 15.0% | 16.1% | 16.0% | 16.0% | 20.0% | 18.0% | 18.0% | 19.0% | 20.1% | 17.1% | 19.1% | 20.0% |
| Other Income | −64.15 | 153 | −40.09 | 5,127 | 35.04 | 9.02 | 5.01 | 29.06 | 28.07 | 0.00 | 37.09 | −77.18 |
| Interest | 29.95 | 24.97 | 29.93 | 28.96 | 30.95 | 30.97 | 31.93 | 30.96 | 30.94 | 30.97 | 29.97 | 30.95 |
| Depreciation | 53.96 | 56.97 | 57.95 | 60.01 | 61.94 | 61.93 | 63.98 | 62.99 | 65.93 | 67.95 | 66.92 | 68.99 |
| Profit before tax | −7.02 | 221 | 28.08 | 5,208 | 159 | 102 | 91.24 | 136 | 168 | 103 | 163 | 78.22 |
| Tax % | 119.9% | 5.0% | 107.9% | 1.0% | 32.9% | 36.9% | 6.0% | 31.0% | 27.0% | 42.9% | 6.0% | 62.0% |
| Exceptional items | −67.99 | 144 | −44.01 | 5,072 | 0.00 | −14.99 | −20.99 | −2.99 | 0.00 | −11.99 | 0.00 | −56.97 |
| Net Profit | −14.96 | 209 | −1.99 | 5,141 | 106 | 63.87 | 85.76 | 93.83 | 121 | 58.89 | 154 | 28.94 |
| EPS (Rs) | −0.61 | 3.58 | −0.47 | 102.73 | 1.93 | 1.13 | 1.57 | 1.64 | 2.11 | 1.00 | 2.70 | 0.30 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,255 | 5,932 | 6,723 | 7,975 | 8,660 | 8,613 | 10,269 | 2,999 | 3,701 | 4,140 | 4,649 | 4,881 |
| Expenses | 4,792 | 5,568 | 6,068 | 6,861 | 7,162 | 7,486 | 8,697 | 2,539 | 3,113 | 3,371 | 3,767 | 3,945 |
| Operating Profit | 446 | 350 | 634 | 1,081 | 1,469 | 1,106 | 1,536 | 448 | 576 | 756 | 866 | 920 |
| OPM % | 8.0% | 6.0% | 9.0% | 14.0% | 17.0% | 13.0% | 15.0% | 15.1% | 16.0% | 18.0% | 19.1% | 18.9% |
| Other Income | 25.06 | 454 | 177 | −155 | −158 | 53.09 | 51.08 | 354 | 32.07 | 5,180 | 93.22 | −12.02 |
| Interest | 189 | 370 | 204 | 205 | 390 | 334 | 306 | 95.92 | 119 | 133 | 123 | 123 |
| Depreciation | 243 | 322 | 298 | 306 | 585 | 618 | 641 | 192 | 220 | 249 | 264 | 270 |
| Profit before tax | 38.09 | 108 | 309 | 411 | 331 | 205 | 639 | 513 | 269 | 5,557 | 572 | 512 |
| Tax % | 78.0% | 9.9% | 7.9% | 9.9% | 5.0% | 12.9% | 6.0% | 7.0% | 20.9% | 2.0% | 25.0% | — |
| Exceptional items | 0.00 | 405 | 119 | −176 | −180 | 0.00 | 0.99 | 0.00 | 0.00 | 5,106 | −21.98 | −68.96 |
| Net Profit | 7.98 | 97.83 | 281 | 366 | 314 | 178 | 599 | 474 | 211 | 5,393 | 426 | 362 |
| EPS (Rs) | 0.19 | 2.51 | 5.30 | 6.58 | 5.53 | 2.95 | 10.50 | 8.49 | 2.58 | 107.44 | 7.47 | 6.11 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4,637.1% | 5.0% | 40.1% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 390 | 402 | 403 | 505 | 504 | 497 | 497 | 499 | 499 | 501 | 499 | 518 |
| Reserves | 1,094 | 16.94 | 1,468 | 2,320 | 2,701 | 2,769 | 2,868 | 3,070 | 3,561 | 3,682 | 2,545 | 4,047 |
| Borrowings | 1,089 | 3,310 | 2,753 | 2,348 | 2,781 | 5,592 | 4,796 | 5,269 | 6,055 | 1,757 | 2,385 | 2,214 |
| Other Liabilities | 1,825 | 1,993 | 2,161 | 2,285 | 2,912 | 3,511 | 3,427 | 3,643 | 4,665 | 11,983 | 1,148 | 1,310 |
| Total Liabilities | 4,397 | 5,722 | 6,785 | 7,457 | 8,898 | 12,369 | 11,588 | 12,480 | 14,779 | 17,923 | 6,578 | 8,089 |
| Fixed Assets | 2,233 | 2,499 | 3,513 | 3,731 | 4,277 | 7,107 | 6,732 | 6,988 | 9,021 | 3,169 | 3,908 | 4,239 |
| CWIP | 197 | 357 | 289 | 401 | 549 | 734 | 932 | 996 | 278 | 169 | 292 | 412 |
| Investments | 2.99 | 38.88 | 31.88 | 37.84 | 21.93 | 33.90 | 62.76 | 44.81 | 79.65 | 16.95 | 244 | 1,163 |
| Other Assets | 1,965 | 2,827 | 2,952 | 3,289 | 4,050 | 4,493 | 3,861 | 4,452 | 5,400 | 14,567 | 2,133 | 2,276 |
| Inventories | 310 | 410 | 525 | 625 | 730 | 959 | 848 | 1,023 | 1,303 | 111 | 91.78 | 90.75 |
| Trade receivables | 884 | 1,342 | 1,287 | 1,547 | 2,029 | 2,367 | 2,019 | 2,020 | 2,337 | 233 | 258 | 307 |
| Cash & equivalents | 304 | 267 | 152 | 300 | 341 | 177 | 281 | 380 | 429 | 113 | 1,379 | 1,326 |
| Total Assets | 4,397 | 5,722 | 6,785 | 7,457 | 8,898 | 12,369 | 11,588 | 12,480 | 14,779 | 17,923 | 6,578 | 8,089 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 237 | 204 | 362 | 538 | 602 | 1,226 | 1,573 | 1,317 | 1,839 | 158 | 426 | 657 |
| Cash from investing activity | −439 | −776 | −1,137 | −523 | −703 | −658 | −333 | −564 | −952 | −879 | 6,024 | −288 |
| Cash from financing activity | 203 | 578 | 654 | 46.06 | 134 | −676 | −1,117 | −686 | −817 | 1,054 | −6,361 | −304 |
| Net cash flow | −0.99 | 4.99 | −122 | 60.86 | 32.92 | −110 | 120 | 64.89 | 65.86 | 331 | 81.87 | 62.87 |
| Capex | 417 | 760 | 933 | 520 | 578 | 531 | 424 | 548 | 848 | 806 | 357 | 478 |
| Free cash flow | −176 | −535 | −564 | 22.99 | 63.91 | 714 | 1,182 | 769 | 994 | −600 | 69.93 | 179 |
| CFO / OP % | 51.0% | 53.0% | 116.0% | 93.0% | 61.0% | 88.0% | 142.9% | 89.0% | 423.9% | 40.0% | 72.0% | 94.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 84 | 94 | 80 | 85 | 94 | 101 | 87 | 73 | 286 | 24 | 24 | 25 |
| Inventory days | 92 | 91 | 101 | 110 | 109 | 137 | 121 | 128 | 611 | 43 | 35 | 31 |
| Days payable | 177 | 186 | 150 | 149 | 152 | 302 | 289 | 266 | 1,399 | 182 | 165 | 167 |
| Cash conversion cycle | −2 | −1 | 30 | 45 | 50 | −65 | −83 | −66 | −503 | −116 | −107 | −112 |
| Working capital days | 68 | 67 | 5 | 58 | 27 | 7 | 4 | 4 | −22 | 271 | −33 | −29 |
| ROCE % | 14.1% | 6.0% | 1.0% | 7.0% | 13.0% | 12.0% | 6.0% | 10.0% | 3.0% | 4.0% | 11.0% | 11.0% |
For the Jun 2026 quarter, Aster DM Quality Care reported sales of ₹1,312 Cr, up 21.6% year on year and net profit of ₹28.94 Cr, down 69.2% year on year. The operating margin was 20.0%.
Aster DM Quality Care's sales for the year to Mar 2026 were ₹4,649 Cr; over the last twelve months they were ₹4,881 Cr.
Net profit for the year to Mar 2026 was ₹426 Cr, and ₹362 Cr over the last twelve months. Earnings per share over the same trailing period were ₹6.11.
Aster DM Quality Care reported borrowings of ₹2,214 Cr at Mar 2026, against cash and equivalents of ₹1,326 Cr.
Cash from operations was ₹657 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹179 Cr.